![David Parkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Parkinson
Directeur/Membre du Conseil chez
The Multiple Myeloma Research Foundation, Inc.
Profil
David R.
Parkinson is the founder of Refuge Biotechnologies, Inc. Currently, Dr. Parkinson serves as Director at Angiocrine Bioscience, Inc. and Director at The Multiple Myeloma Research Foundation, Inc. Formerly, Dr. Parkinson was President, Chief Executive Officer & Director at ESSA Pharma, Inc. from 2016 to 2025, President, Chief Executive Officer & Director at Nodality, Inc. from 2007 to 2012, Chairman-Clinical Advisory Board at Zyngenia, Inc. from 2012 to 2014, Independent Director at Ambit Biosciences Corp.
from 2013 to 2014, Independent Non-Executive Director at 3SBio, Inc. from 2014 to 2021, Independent Director at Tocagen, Inc. from 2015 to 2020, Director at Abbott Biotherapeutics Corp.
from 2008 to 2010, Associate Director-Cancer Therapy Medicine at National Cancer Institute in 1997, Director at American Association for Cancer Research from 2006 to 2009, Director at Pierian Biosciences LLC from 2016 to 2018, VP-Oncology Development & Commercialization at Amgen, Inc. from 2003 to 2006, Senior VP-Oncology Research & Development at Biogen, Inc. in 2007, and VP-Global Clinical Oncology Development at Novartis Corp.
in 2003.
Other former roles include Chairman at US Food & Drug Administration, Independent Director at Threshold Pharmaceuticals, Inc., Director at Cerulean Pharma, Inc., Director at Multiple Myeloma Research Consortium, Director at Ontario Institute for Cancer Research, Director at Realm Therapeutics Plc, Independent Director at CTI BioPharma Corp., Vice President-Global Clinical Oncology at Novartis International AG, Venture Partner at NEA Management Co. LLC, Principal at The University of Texas at Austin, Principal at Tufts University, Principal at The University of Texas M.D.
Anderson Cancer Center, President at International Society for Biological Therapy of Cancer, and Partner at New Enterprise Associates (India) LLC.
Education includes a doctorate degree conferred in 1977 from the University of Toronto Faculty of Medicine.
Postes actifs de David Parkinson
| Sociétés | Poste | Début |
|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Directeur/Membre du Conseil | 22/11/2010 |
Angiocrine Bioscience, Inc.
 Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Directeur/Membre du Conseil | - |
Anciens postes connus de David Parkinson
| Sociétés | Poste | Fin |
|---|---|---|
| ESSA PHARMA INC. | Directeur Général | 09/10/2025 |
| 3SBIO INC. | Directeur/Membre du Conseil | 29/06/2021 |
| FORTE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 15/06/2020 |
Pierian Biosciences LLC
 Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic development and laboratory service company | Directeur/Membre du Conseil | 01/03/2018 |
| AMBIT BIOSCIENCES CORP | Directeur/Membre du Conseil | 10/11/2014 |
Formation de David Parkinson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
31
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
3SBio, Inc.
 3SBio, Inc. BiotechnologyHealth Technology Engages in research, development, manufacturing and marketing of biopharmaceutical products | Health Technology |
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Develops biopharmaceutical drugs | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage cell and gene therapy company | Commercial Services |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
Multiple Myeloma Research Consortium
 Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development | Commercial Services |
International Society for Biological Therapy of Cancer
 International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives | Commercial Services |
New Enterprise Associates (India) LLC | |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Provides research on the prevention, early detection, diagnosis, and treatment of cancer | Health Services |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
University of Toronto Faculty of Medicine
 University of Toronto Faculty of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Refuge Biotechnologies, Inc.
 Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Commercial Services |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Operates as a diagnostic development and laboratory service company | Health Services |
